Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 408
Selected: 0
NCT IDTitle
NCT00127036Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)
NCT03554343Sun May Arise on SMA : Newborn Screening of Spinal Muscular Atrophy in Belgium
NCT01457144Study of Mantle Cell Lymphoma Treatment by RiBVD
NCT00291616Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B
NCT00144976Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma
NCT02060669Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer
NCT03577197Southeast Netherlands Advanced Metastatic Breast Cancer Registry
NCT02894853Lung Cancer Early Molecular Assessment Trial
NCT00335595Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients
NCT00189683Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy
NCT03385668Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies
NCT00275535The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients
NCT01066689Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation
NCT01249638Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC
NCT04245085ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma
NCT01015339Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction
NCT02389283Reduced Ultrasound Counts in Rheumatoid Arthritis
NCT01259856Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)
NCT00223301Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis
NCT01640405Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells
NCT03802604Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer
NCT04059081A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based Assessment
NCT02562378T-DM1 and Non-pegylated Liposomal Doxorubicin in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer
NCT04470947Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies
NCT03961698Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma
NCT02925234The Drug Rediscovery Protocol (DRUP Trial)
NCT00552201TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic
NCT03691077Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714
NCT00484328Ribavirin, Its Dosing Regime
NCT03526601Screening Of Adult urBan pOpulation To diAgnose Heart Failure
NCT03322865Obinutuzumab in Marginal Zone Lymphoma
NCT02303119Follicular Lymphoma IV/SC Rituximab Therapy (FLIRT)
NCT01167049Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis
NCT05966233R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma
NCT03779191Alectinib in Combination With Bevacizumab in ALK Positive NSCLC
NCT01384838Exercise Training in Postmenopausal Patients With Breast Cancer
NCT01817452A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol
NCT00944684High Dose Ribavirin in the Treatment of Chronic Hepatitis C
NCT01101295The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.
NCT04808245A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas
NCT00957866Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity
NCT00476164Study of Rituximab to Treat Chronic Renal Transplant Rejection
NCT00485589A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate (FILM)
NCT00620269Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III
NCT00198146Prevention of Diabetes Progression Trial (PDPT)
NCT01633346Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis Patients
NCT00347438Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
NCT04939662Olaparib and Bevacizumab in Relapsed Small Cell Lung Cancer Subjects
NCT01185223Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation
NCT02383290The Implementation of Pharmacogenomics Into Primary Care in British Columbia